1. Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update

   • Partha Roy
   • Srija Sur
   • Wong Tin Wui

   Review Article 16 May 2022 Pages: 761 - 777

   

2. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy

   • Zhila Khodabandeh
   • Mohammad Valilo
   • Abbas Pirpour Tazehkand

   Review Article 18 May 2022 Pages: 778 - 789

   

3. Comparative study of the usefulness of adjunctive tomosynthesis in breast cancer screening by mammography and ultrasound in Japan

   • Kanako Ban
   • Hiroko Tsunoda
   • Mami Inagaki

   Original Article 18 May 2022 Pages: 790 - 795

   

4. Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study

   • Yuichiro Kikawa
   • Takeshi Kotake
   • Masakazu Toi

   Original Article 23 April 2022 Pages: 796 - 807

   

5. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer

   • Yuko Minoura
   • Masato Takahashi
   • Akihiro Sakurai

   Original Article 31 May 2022 Pages: 808 - 813

   

6. miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast

   • Ji Won Woo
   • Hye Yeon Choi
   • So Yeon Park

   Original Article 22 April 2022 Pages: 814 - 824

   

7. Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)

   • Akemi Kataoka
   • Takayuki Ueno
   • Shinji Ohno

   Original Article 23 May 2022 Pages: 825 - 834

   

8. Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema

   • Joseph Kyu-hyung Park
   • Junggyo Seo
   • Yujin Myung

   Original Article 12 May 2022 Pages: 835 - 843

   

9. Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

   • Mengdi Chen
   • Weilin Chen
   • Li Zhu

   Original Article Open access 21 June 2022 Pages: 844 - 853

   

10. Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties

    • Xiang Li
    • Yuying Wang
    • Bin Liu

    Original Article 12 May 2022 Pages: 854 - 868

    

11. Relevance of the MHC region for breast cancer susceptibility in Asians

    • Peh Joo Ho
    • Alexis Jiaying Khng
    • Jingmei Li

    Original Article Open access 11 May 2022 Pages: 869 - 879

    

12. Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial

    • Shi-Qian Lin
    • Chih-Ming Su
    • Ka-Wai Tam

    Original Article 19 May 2022 Pages: 880 - 888

    

13. Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database

    • Jiwoong Jung
    • Ki-Tae Hwang
    • Tae-Hoon Yeo

    Original Article Open access 26 May 2022 Pages: 889 - 898

    

14. Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD155

    • Hossein Vazeh
    • Emad Behboudi
    • Abdolvahab Moradi

    Original Article 01 June 2022 Pages: 899 - 907

    

15. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6

    • Xingxing Zhang
    • Xiaojun Zhao
    • Peng Ge

    Original Article 09 June 2022 Pages: 908 - 920

    

16. BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome

    • Ana Blatnik
    • Domen Ribnikar
    • Mateja Krajc

    Case Report Open access 05 April 2022 Pages: 921 - 927

    

17. Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results

    • Takayoshi Uematsu

    Rapid Communication 04 May 2022 Pages: 928 - 931